Therapeutic potentials of short interfering RNAs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Link
http://link.springer.com/article/10.1007/s00253-017-8433-z/fulltext.html
Reference105 articles.
1. Abu-Rub MT, Newland B, Naughton M, Wang W, McMahon S, Pandit A (2016) Non-viral xylosyltransferase-1 siRNA delivery as an effective alternative to chondroitinase in an in vitro model of reactive astrocytes. Neuroscience 339:267–275
2. Aigner A (2006) Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 124(1):12–25
3. Aliabadi HM, Mahdipoor P, Bisoffi M, Hugh JC, Uludağ H (2016) Single and combinational siRNA therapy of cancer cells: probing changes in targeted and nontargeted mediators after siRNA treatment. Mol Pharm 13(12):4116–4128
4. Alvarado-Facundo E, Gao Y, Ribas-Aparicio RM, Jiménez-Alberto A, Weiss CD, Wang W (2015) Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface. J Virol 89(4):1975–1985
5. Antonioli L, Pacher P, Vizi ES, Haskó G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19(6):355–367
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes;Molecular Therapy - Nucleic Acids;2024-09
2. Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder cancer;Journal of Cancer;2024
3. Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment;Clinical and Translational Science;2023-08-31
4. The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering;International Journal of Molecular Sciences;2023-04-28
5. Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies;Frontiers in Pharmacology;2022-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3